Olaf Hardt

Olaf Hardt

Company: Miltenyi Biotec

Job title: Senior Manager, Research and Development


Identification of Target Candidates for Pancreatic Adenocarcinoma Immunotherapy 9:30 am

Miltenyi Biotec presents the MACSima Ultra-high content imaging platform Learn how MICS technology enables you to visualize hundreds of markers from fixed tissue to lift your sample analysis to the next level See a comprehensive workflow for the identification of new target candidatesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.